Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 9Phase 4 2Phase 3 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1Advanced Cancer 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Quality of Life × Clear all
NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Mansoura University

Phase 3 Unknown
116 enrolled
Breast

Breast Neoplasms

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed
700 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡